Prokidney appoints libbie parker mckenzie, md, fasn as chief medical officer

Winston-salem, n.c., april 28, 2022 (globe newswire) -- prokidney lp (prokidney), a leading clinical-stage cellular therapeutics company focused on the treatment of chronic kidney disease (ckd) and prevention of both end-stage renal disease (esrd) and the need for dialysis, today announced the appointment of libbie parker mckenzie, md, fasn as chief medical officer.
PROK Ratings Summary
PROK Quant Ranking